Carolinas HealthCare System

Research and Clinical Trials

Title  
Roche BN29552
Brief Description  
This study is to evaluate the safety and efficacy of crenezumab as compared with placebo in patients with prodromal to mild Alzheimer's Disease.
Who may be Eligible  
Male or female 50-85 years old with Alzheimer's disease diagnosis
Specialty/Disorder  
Alzheimer´s Disease
Start Date  
04/01/2016
IRB Number  
04-16-01A
Principal Investigator  
Tcheremissine, Oleg
Contact Name  
Dineen

For More Information, Contact   Dineen  Gardner , BA
Phone:  (704) 446-7511  Fax:  (704) 446-7505 
Email:  Dineen.Gardner@carolinashealthcare.org
Close